Congenital transmission of Chagas disease: A clinical approach

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 8, 2010, Pages 945-956

  Oliveira, Inés ^a   Torrico, Faustino ^b   Muoz, Jose ^a   Gascon, Joaquim ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSIDAD MAYOR DE SAN SIMÓN   (Bolivia)

Author keywords

benznidazole; congenital Chagas; microhematocrit; nifurtimox; PCR; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX;

ABDOMINAL PAIN; ANOREXIA; ARTHRALGIA; BREAST FEEDING; CHAGAS DISEASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPIGASTRIC PAIN; HEADACHE; HEALTH PROGRAM; HUMAN; IMMIGRANT; IMMUNE RESPONSE; IMMUNOCOMPETENCE; LEUKOPENIA; MACULOPAPULAR RASH; NAUSEA; NEUROMUSCULAR DISEASE; PARASITE EXAMINATION; PARASITE LOAD; PARASITEMIA; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRURITUS; REINFECTION; REVIEW; SEROLOGY; SKIN MANIFESTATION; TRYPANOSOMA CRUZI; VECTOR CONTROL; VERTICAL TRANSMISSION; VOMITING; WESTERN HEMISPHERE; ZOONOSIS;

ADOLESCENT; ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; CHAGAS DISEASE; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LATIN AMERICA; NITROIMIDAZOLES; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 77955577363     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.74     Document Type: Review

References (127)

1. Pays JF. Chagas Carlos Justiniano Ribeiro (1879-1934). Bull. Soc. Pathol. Exot. 102(5), 276-279 (2009).
2. Voelker R. A century after Chagas disease discovery, hurdles to tackling the infection remain. JAMA 302(10), 1045-1047 (2009).
3. Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol. 22(12), 583-588 (2006).
4. Sosa-Estani S, Segura EL. Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina. Curr. Opin. Infect. Dis. 19(6), 583-587 (2006).
5. Coura JR. Chagas disease: what is known and what is needed - a background article. Mem. Inst. Oswaldo Cruz 102(Suppl. 1), 113-122 (2007).
6. Reithinger R, Tarleton RL, Urbina JA, Kitron U, Gurtler RE. Eliminating Chagas disease: challenges and a roadmap. Br. Med. J. 338, b1283 (2009).
7. Wanderley DM, de Carvalho ME, Mantegazza E, Yasumaru S, Barata LC. Transfusional Chagas infection detected in the program for the control of Chagas disease in the state of Sao Paulo (Brazil). Rev. Saude Publica 26(3), 203-205 (1992).
8. Kun H, Moore A, Mascola L et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin. Infect. Dis. 48(11), 1534-1540 (2009).
9. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 115(1-2), 14-21 (2010).
10. Pereira KS, Schmidt FL, Guaraldo AM et al. Chagas disease as a foodborne illness. J. Food Prot. 72(2), 441-446 (2009).
11. Yoshida N. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Mem. Inst. Oswaldo Cruz 104(Suppl. 1), 101-107 (2009).
12. Beltrao Hde B, Cerroni Mde P, Freitas DR et al. Investigation of two outbreaks of suspected oral transmission of acute Chagas disease in the Amazon region, Para State, Brazil, in 2007. Trop. Doct. 39(4), 231-232 (2009).
13. Valente SA, da Costa Valente V, das Neves Pinto AY et al. Analysis of an acute Chagas disease outbreak in the Brazilian Amazon: human cases, triatomines, reservoir mammals and parasites. Trans. R. Soc. Trop. Med. Hyg. 103(3), 291-297 (2009).
14. Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin. Microbiol. Rev. 14(4), 659-688 (2001).
15. WHO. Chagas disease: control and elimination. Report by the Secretariat. In: Sixty-Second World Health Assembly. Provisional Agenda Item 12.12. A62/17.20 (2009).
16. Okumura M, Aparecida dos Santos V, Camargo ME, Schultz R, Zugaib M. Prenatal diagnosis of congenital Chagas disease (American trypanosomiasis). Prenat. Diagn. 24(3), 179-181 (2004).
17. Gurtler RE, Segura EL, Cohen JE. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg. Infect. Dis. 9(1), 29-32 (2003).
18. Jackson Y, Myers C, Diana A et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg. Infect. Dis. 15(4), 601-603 (2009).
19. Munoz J, Gomez i Prat J, Gallego M et al. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop. 111(1), 51-55 (2009).
20. Muñoz J, Portus M, Corachan M, Fumado V, Gascon J. Congenital Trypanosoma cruzi infection in a non-endemic area. Trans. R. Soc. Trop. Med. Hyg. 101(11), 1161-1162 (2007).
21. Riera C, Guarro A, Kassab HE et al. Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am. J. Trop. Med. Hyg. 75(6), 1078-1081 (2006).
22. Piron M, Verges M, Munoz J et al. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 48(9), 1862-1868 (2008).
23. Leiby DA, Herron RM Jr, Garratty G, Herwaldt BL. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J. Infect. Dis. 198(4), 609-613 (2008).
24. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 115 (1-2), 22-27 (2010).
25. Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL. Chagas disease and the US blood supply. Curr. Opin. Infect. Dis. 21(5), 476-482 (2008).
26. Castro E. Chagas disease: lessons from routine donation testing. Transfus. Med. 19(1), 16-23 (2009).
27. Yamagata Y, Nakagawa J. Control of Chagas disease. Adv. Parasitol. 61, 129-165 (2006).
28. Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin. Microbiol. Rev. 18(1), 12-29 (2005).
29. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem. Inst. Oswaldo Cruz 104(Suppl. 1), 17-30 (2009).
30. Guhl F, Pinto N, Aguilera G. Sylvatic triatominae: a new challenge in vector control transmission. Mem. Inst. Oswaldo Cruz 104(Suppl. 1), 71-75 (2009).
31. Massad E. The elimination of Chagas disease from Brazil. Epidemiol. Infect. 136(9), 1153-1164 (2008).
32. Uruguay declared free of Chagas disease transmission. TDR News 56, 6 (1998).
33. Dias JC. Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation, and perspectives. Mem. Inst. Oswaldo Cruz 102(Suppl. 1), 11-18 (2007).
34. Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gurtler RE. The challenges of Chagas disease - grim outlook or glimmer of hope. PLoS Med. 4(12), e332 (2007).
35. Chippaux JP, Santalla JA, Postigo JR et al. Sensitivity and specificity of Chagas Stat-Pak test in Bolivia. Trop. Med. Int. Health 14(7), 732-735 (2009).
36. Sosa-Estani S, Gamboa-Leon MR, Del Cid-Lemus J et al. Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico. Am. J. Trop. Med. Hyg. 79(5), 755-759 (2008).
37. Russomando G, de Tomassone MM, de Guillen I et al. Treatment of congenital Chagas disease diagnosed and followed up by the polymerase chain reaction. Am. J. Trop. Med. Hyg. 59(3), 487-491 (1998).
38. Russomando G, Almiron M, Candia N et al. Implementation and evaluation of a locally sustainable system of prenatal diagnosis to detect cases of congenital Chagas disease in endemic areas of Paraguay. Rev. Soc. Bras. Med. Trop. 38(Suppl. 2), 49-54 (2005).
39. Torrico F, Alonso-Vega C, Suarez E et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am. J. Trop. Med. Hyg. 70(2), 201-209 (2004).
40. Salas NA, Cot M, Schneider D et al. Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia. Trop. Med. Int. Health 12(12), 1498-1505 (2007).
41. Brutus L, Schneider D, Postigo J et al. Congenital Chagas disease: diagnostic and clinical aspects in an area without vectorial transmission, Bermejo, Bolivia. Acta Trop. 106(3), 195-199 (2008).
42. Blanco SB, Segura EL, Cura EN et al. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop. Med. Int. Health 5(4), 293-301 (2000).
43. Reiche EM, Morimoto HK, Farias GN et al. Prevalence of American trypanosomiasis, syphilis, toxoplasmosis, rubella, hepatitis B, hepatitis C, human immunodeficiency virus infection, assayed through serological tests among pregnant patients, from 1996 to 1998, at the Regional University Hospital Norte do Parana. Rev. Soc. Bras. Med. Trop. 33(6), 519-527 (2000).
44. Mendoza Ticona CA, Cordova Benzaquen E, Ancca Juarez J et al. The prevalence of Chagas disease in puerperal women and congenital transmission in an endemic area of Peru. Rev. Panam. Salud Publica 17(3), 147-153 (2005).
45. Garcia A, Bahamonde M, Verdugo S et al. Trypanosoma cruzi transplacental infection: situation in Chile. Rev. Med. Chil. 129(3), 330-332 (2001).
46. Brutus L, Schneider D, Postigo J et al. Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans. R. Soc. Trop. Med. Hyg. 101(11), 1159-1160 (2007).
47. Brutus L, Santalla JA, Salas NA, Schneider D, Chippaux JP. Screening for congenital infection by Trypanosoma cruzi in France. Bull. Soc. Pathol. Exot. 102(5), 300-309 (2009).
48. Muñoz J, Coll O, Juncosa T et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin. Infect. Dis. 48(12), 1736-1740 (2009).
49. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem. Inst. Oswaldo Cruz 102(Suppl. 1), 75-85 (2007).
50. Di Pentima MC, Hwang LY, Skeeter CM, Edwards MS. Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin. Infect. Dis. 28(6), 1281-1285 (1999).
51. Paricio-Talayero JM, Benlloch-Muncharaz MJ, Collar-del- Castillo JI et al. Epidemiological surveillance of vertically-transmitted Chagas disease at three maternity hospitals in the Valencian Community. Enferm. Infecc. Microbiol. Clin. 26(10), 609-613 (2008).
52. Gonzalez-Granado LI, Rojo-Conejo P, Ruiz-Contreras J, Gonzalez-Tome MI. Chagas disease travels to Europe. Lancet 373(9680), 2025 (2009).
53. Hernandez-Matheson IM, Frankowski RF, Held B. Foeto-maternal morbidity in the presence of antibodies to Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg. 77(3), 405-411 (1983).
54. Schenone H, Contreras MC, Borgono JM, Rojas A, Villarroel F. Congenital Chagas disease in Chile. Longitudinal study of the reproductivity of women with or without Chagas disease and of some parasitological and clinical parameters of them and their corresponding children. Bol. Chil. Parasitol. 40(1-2), 24-29 (1985).
55. Bittencourt AL. Possible risk factors for vertical transmission of Chagas disease. Rev. Inst. Med. Trop. Sao Paulo 34(5), 403-408 (1992).
56. Bittencourt AL, Garcia AG. The placenta in hematogenous infections. Pediatr. Pathol. Mol. Med. 21(4), 401-432 (2002).
57. Hermann E, Truyens C, Alonso-Vega C et al. Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon-g in response to parasite antigens. J. Infect. Dis. 189(7), 1274-1281 (2004).
58. Yadon ZE, Schmunis GA. Congenital Chagas disease: estimating the potential risk in the United States. Am. J. Trop. Med. Hyg. 81(6), 927-933 (2009).
59. Sosa-Estani S, Dri L, Touris C et al. Vectorial and congenital transmission of Trypanosoma cruzi in Las Lomitas, Formosa. Medicina (B. Aires) 69(4), 424-430 (2009).
60. Pan American Health Organization (PAHO). Organización Panamericana de la Salud. Estimación cuantitativa de la Enfermedad de Chagas en las Ameritas (2006).
61. Di Pentima MC, Edwards MS. Enzyme-linked immunosorbent assay for IgA antibodies to Trypanosoma cruzi in congenital infection. Am. J. Trop. Med. Hyg. 60(2), 211-214 (1999).
62. Pehrson PO, Wahlgren M, Bengtsson E. Asymptomatic congenital Chagas disease in a 5-year-old child. Scand. J. Infect. Dis. 13(4), 307-308 (1981).
63. Flores-Chavez M, Faez Y, Olalla JM et al. Fatal congenital Chagas disease in a non-endemic area: a case report. Cases J. 1(1), 302 (2008).
64. Carrilero B, Quesada JJ, Alfayate S, Segovia M. Congenital Chagas disease in a newborn of a Bolivian mother. Enferm. Infecc. Microbiol. Clin. 27(8), 486-487 (2009).
65. WHO. Control of Chagas disease. World Health Organ. Tech. Rep. Ser. 905, i-vi, 1-109, back cover (2002).
66. Castro C, Prata A, Macedo V. The influence of the parasitemia on the evolution of the chronic Chagas disease. Rev. Soc. Bras. Med. Trop. 38(1), 1-6 (2005).
67. Garcia MM, De Rissio AM, Villalonga X, Mengoni E, Cardoni RL. Soluble tumor necrosis factor (TNF) receptors (sTNF-R1 and -R2) in pregnant women chronically infected with Trypanosoma cruzi and their children. Am. J. Trop. Med. Hyg. 78(3), 499-503 (2008).
68. Cardoni RL, Garcia MM, De Rissio AM. Proinflammatory and anti-inflammatory cytokines in pregnant women chronically infected with Trypanosoma cruzi. Acta Trop. 90(1), 65-72 (2004).
69. Bern C, Verastegui M, Gilman RH et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin. Infect. Dis. 49(11), 1667-1674 (2009).
70. Bern C, Montgomery SP, Herwaldt BL et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 298(18), 2171-2181 (2007).
71. Torrico F, Vega CA, Suarez E et al. Are maternal re-infections with Trypanosoma cruzi associated with higher morbidity and mortality of congenital Chagas disease? Trop. Med. Int. Health 11(5), 628-635 (2006).
72. Moretti E, Basso B, Castro I et al. Chagas disease: study of congenital transmission in cases of acute maternal infection. Rev. Soc. Bras. Med. Trop. 38(1), 53-55 (2005).
73. Triquell MF, Diaz-Lujan C, Freilij H, Paglini P, Fretes RE. Placental infection by two subpopulations of Trypanosoma cruzi is conditioned by differential survival of the parasite in a deleterious placental medium and not by tissue reproduction. Trans. R. Soc. Trop. Med. Hyg. 103(10), 1011-1018 (2009).
74. Zingales B, Andrade SG, Briones MR et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem. Inst. Oswaldo Cruz 104(7), 1051-1054 (2009).
75. Macedo AM, Machado CR, Oliveira RP, Pena SD. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. Mem. Inst. Oswaldo Cruz 99(1), 1-12 (2004).
76. Vago AR, Andrade LO, Leite AA et al. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am. J. Pathol. 156(5), 1805-1809 (2000).
77. Burgos JM, Altcheh J, Bisio M et al. Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease. Int. J. Parasitol. 37(12), 1319-1327 (2007).
78. Freitas JM, Andrade LO, Pires SF et al. The MHC gene region of murine hosts influences the differential tissue tropism of infecting Trypanosoma cruzi strains. PLoS One 4(4), e5113 (2009).
79. Miles MA, Feliciangeli MD, de Arias AR. American trypanosomiasis (Chagas disease) and the role of molecular epidemiology in guiding control strategies. Br. Med. J. 326(7404), 1444-1448 (2003).
80. Rivero A. Nitric oxide: an antiparasitic molecule of invertebrates. Trends Parasitol. 22(5), 219-225 (2006).
81. Orange SJ, Painter D, Horvath J et al. Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia. Clin. Exp. Pharmacol. Physiol. 30(5-6), 376-381 (2003).
82. Corrales RM, Mora MC, Negrette OS et al. Congenital Chagas disease involves Trypanosoma cruzi sub-lineage IId in the northwestern province of Salta, Argentina. Infect. Genet. Evol. 9(2), 278-282 (2009).
83. Virreira M, Truyens C, Alonso-Vega C et al. Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns. Am. J. Trop. Med. Hyg. 77(1), 102-106 (2007).
84. Shippey SH 3rd, Zahn CM, Cisar MM, Wu TJ, Satin AJ. Use of the placental perfusion model to evaluate transplacental passage of Trypanosoma cruzi. Am. J. Obstet. Gynecol. 192(2), 586-591 (2005).
85. Fernandez-Aguilar S, Lambot MA, Torrico F et al. Placental lesions in human Trypanosoma cruzi infection. Rev. Soc. Bras. Med. Trop. 38(Suppl. 2), 84-86 (2005).
86. Altemani AM, Bittencourt AL, Lana AM. Immunohistochemical characterization of the inflammatory infiltrate in placental Chagas disease: a qualitative and quantitative analysis. Am. J. Trop. Med. Hyg. 62(2), 319-324 (2000).
87. Teixeira AR, Nascimento RJ, Sturm NR. Evolution and pathology in chagas disease - a review. Mem. Inst. Oswaldo Cruz 101(5), 463-491 (2006).
88. Bittencourt AL, Garcia AG. Pathogenesis and pathology of hematogenous infections of the fetus and newborn. Pediatr. Pathol. Mol. Med. 21(4), 353-399 (2002).
89. Padilla AM, Bustamante JM, Tarleton RL. CD8+ T cells in Trypanosoma cruzi infection. Curr. Opin. Immunol. 21(4), 385-390 (2009).
90. Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev. Soc. Bras. Med. Trop. 36(6), 767-771 (2003).
91. Freilij H, Altcheh J. Congenital Chagas disease: diagnostic and clinical aspects. Clin. Infect. Dis. 21(3), 551-555 (1995).
92. Altcheh J, Biancardi M, Lapena A, Ballering G, Freilij H. Congenital Chagas disease: experience in the Hospital de Ninos, Ricardo Gutierrez, Buenos Aires, Argentina. Rev. Soc. Bras. Med. Trop. 38(Suppl. 2), 41-45 (2005).
93. Moya P, Basso B, Moretti E. Congenital Chagas disease in Cordoba, Argentina: epidemiological, clinical, diagnostic, and therapeutic aspects. Experience of 30 years of follow up. Rev. Soc. Bras. Med. Trop. 38(Suppl. 2), 33-40 (2005).
94. Shikanai-Yasuda MA, Lopes MH, Tolezano JE et al. Acute Chagas disease: transmission routes, clinical aspects and response to specific therapy in diagnosed cases in an urban center. Rev. Inst. Med. Trop. Sao Paulo 32(1), 16-27 (1990).
95. Muñoz Casas del Valle P, Thiermann E, Atias M, Acevedo CS. Enfermedad de Chagas congénita sintomática en recién nacidos y lactantes. Rev. Chil. Pediatr. 63(4), 196-202 (1992).
96. Garcia-Bournissen F, Altcheh J, Giglio N et al. Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina. Paediatr. Drugs 11(1), 33-37 (2009).
97. Virreira M, Torrico F, Truyens C et al. Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 68(5), 574-582 (2003).
98. Rosenblatt JE. Laboratory diagnosis of infections due to blood and tissue parasites. Clin. Infect. Dis. 49(7), 1103-1108 (2009).
99. Torrico MC, Solano M, Guzman JM et al. Estimation of the parasitemia in Trypanosoma cruzi human infection: high parasitemias are associated with severe and fatal congenital Chagas disease. Rev. Soc. Bras. Med. Trop. 38(Suppl. 2), 58-61 (2005).
100. Gomes YM, Lorena VM, Luquetti AO. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem. Inst. Oswaldo Cruz 104(Suppl. 1), 115-121 (2009).
101. Britto CC. Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem. Inst. Oswaldo Cruz 104(Suppl. 1), 122-135 (2009).
102. Piron M, Fisa R, Casamitjana N et al. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop. 103(3), 195-200 (2007).
103. Schijman AG, Altcheh J, Burgos JM et al. Aetiological treatment of congenital Chagas disease diagnosed and monitored by the polymerase chain reaction. J. Antimicrob. Chemother. 52(3), 441-449 (2003).
104. Mora MC, Sanchez Negrette O, Marco D et al. Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology. J. Parasitol. 91(6), 1468-1473 (2005).
105. Chippaux JP, Clavijo AN, Santalla JA et al. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole. Trop. Med. Int. Health 15(1), 87-93 (2010).
106. Mallimaci MC, Sosa-Estani S, Russomando G et al. Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina. Am. J. Trop. Med. Hyg. 82(1), 55-59 (2010).
107. Breniere SF, Yaksic N, Telleria J et al. Immune response to Trypanosoma cruzi shed acute phase antigen in children from an endemic area for Chagas disease in Bolivia. Mem. Inst. Oswaldo Cruz 92(4), 503-507 (1997).
108. Adams ER, Hamilton PB. New molecular tools for the identification of trypanosome species. Future Microbiol. 3, 167-176 (2008).
109. Bittencourt AL, Sadigursky M, Da Silva AA et al. Evaluation of Chagas disease transmission through breast-feeding. Mem. Inst. Oswaldo Cruz 83(1), 37-39 (1988).
110. OMS. Reporte sobre la enfermedad de Chagas. Grupo de trabajo científico 17-20 de abril de 2005 - Actualizado en julio de 2007. Buenos Aires, Argentina (2005).
111. Marin-Neto JA, Rassi A Jr, Avezum A Jr, Mattos AC, Rassi A. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem. Inst. Oswaldo Cruz 104(Suppl. 1), 319-324 (2009).
112. Viotti R, Vigliano C, Lococo B et al. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev. Anti Infect. Ther. 7(2), 157-163 (2009).
113. Neto EC, Rubin R, Schulte J, Giugliani R. Newborn screening for congenital infectious diseases. Emerg. Infect. Dis. 10(6), 1068-1073 (2004).
114. de Andrade AL, Zicker F, de Oliveira RM et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348(9039), 1407-1413 (1996).
115. Sosa Estani S, Segura EL, Ruiz AM et al. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas disease. Am. J. Trop. Med. Hyg. 59(4), 526-529 (1998).
116. Yun O, Lima MA, Ellman T et al. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Medecins Sans Frontieres. PLoS Negl. Trop. Dis. 3(7), e488 (2009).
117. Rodrigues Coura J. Present situation and new strategies for Chagas disease chemotherapy: a proposal. Mem. Inst. Oswaldo Cruz 104(4), 549-554 (2009).
118. Rodriques Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 97(1), 3-24 (2002).
119. Sosa-Estani S, Belizan JM, Althabe F, Rubinstein A. The need of a neonatal preparation for Chagas disease. PLoS Med. 2(11), e387 (2005).
120. Ribeiro I, Sevcsik AM, Alves F et al. New, improved treatments for Chagas disease: from the R&D pipeline to the patients. PLoS Negl. Trop. Dis. 3(7), e484 (2009).
121. Lamas MC, Villaggi L, Nocito I et al. Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole. Int. J. Pharm. 307(2), 239-243 (2006).
122. Urbina JA. Chemotherapy of Chagas disease. Curr. Pharm. Des. 8(4), 287-295 (2002).
123. Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission. Rev. Soc. Bras. Med. Trop. 42(5), 484-487 (2009).
124. Suarez E, Alonso-Vega C, Torrico F, Cordova M. Integral treatment of congenital Chagas disease: the Bolivian experience. Rev. Soc. Bras. Med. Trop. 38(Suppl. 2), 21-23 (2005).
125. Altcheh J, Corral R, Biancardi MA, Freilij H. Anti-F2/3 antibodies as cure marker in children with congenital Trypanosoma cruzi infection. Medicina (B. Aires), 63(1), 37-40 (2003).
126. Galvao LM, Chiari E, Macedo AM et al. PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy. J. Clin. Microbiol. 41(11), 5066-5070 (2003).
127. Gascon J, Pinazo MJ. Controlling vertical transmission of Trypanosoma cruzi: the biggest challenge for imported disease in Spain. Enferm. Infecc. Microbiol. Clin. 26(10), 607-608 (2008).